Spyros Papapetropoulos - 01 Jul 2024 Form 3 Insider Report for BIONOMICS LIMITED/FI (NEUP)

Role: Chief Executive Officer, Director
Signature: /s/ Spyridon Papapetropoulos
Issuer symbol: NEUP
Transactions as of: 01 Jul 2024
Net transactions value: $0
Form type: 3
Filing time: 08 Jul 2024, 06:10:20 UTC
Previous filing: 07 Jun 2024
Next filing: 18 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BNOX	Ordinary Shares						5,999,940	01 Jul 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	6,766,754	$0.0321	Direct
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,688	$0.0321	Direct
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,689	$0.0321	Direct
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,688	$0.0321	Direct	F2
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,689	$0.0321	Direct	F3
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,688	$0.0321	Direct	F4
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,689	$0.0321	Direct	F5
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,688	$0.0321	Direct	F6
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,689	$0.0321	Direct	F7
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,688	$0.0321	Direct	F8
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,689	$0.0321	Direct	F9
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,688	$0.0321	Direct	F10
holding	BNOX	Option (right to buy)							01 Jul 2024	Ordinary Shares	1,691,688	$0.0321	Direct	F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Some Ordinary Shares are represented by American Depositary Shares.
F2	Granted on December 16, 2022. Vesting to occur on September 16, 2024, provided Mr. Papapetropoulos is still employed on such date.
F3	Granted on December 16, 2022. Vesting to occur on December 16, 2024, provided Mr. Papapetropoulos is still employed on such date.
F4	Granted on December 16, 2022. Vesting to occur on March 16, 2025, provided Mr. Papapetropoulos is still employed on such date.
F5	Granted on December 16, 2022. Vesting to occur on June 16, 2025, provided Mr. Papapetropoulos is still employed on such date.
F6	Granted on December 16, 2022. Vesting to occur on September 16, 2025, provided Mr. Papapetropoulos is still employed on such date.
F7	Granted on December 16, 2022. Vesting to occur on December 16, 2025, provided Mr. Papapetropoulos is still employed on such date.
F8	Granted on December 16, 2022. Vesting to occur on March 16, 2026, provided Mr. Papapetropoulos is still employed on such date.
F9	Granted on December 16, 2022. Vesting to occur on June 16, 2026, provided Mr. Papapetropoulos is still employed on such date.
F10	Granted on December 16, 2022. Vesting to occur on September 16, 2026, provided Mr. Papapetropoulos is still employed on such date.
F11	Granted on December 16, 2022. Vesting to occur on December 16, 2026, provided Mr. Papapetropoulos is still employed on such date.